Jeffrey G. Suico
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Electronic Health Records Systems, Lipoproteins and Cardiovascular Health, Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Diabetes Management and Research
Most-Cited Works
- → LOINC, a Universal Standard for Identifying Laboratory Observations: A 5-Year Update(2003)572 cited
- → The Regenstrief Medical Record System: a quarter century experience(1999)400 cited
- → Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation(2023)167 cited
- → Electronic Laboratory Reporting: Barriers, Solutions and Findings(2001)91 cited
- → Units of Measure in Clinical Information Systems(1999)54 cited
- → What is done, what is needed and what is realistic to expect from medical informatics standards(1998)47 cited
- → Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human(2015)37 cited
- → Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults(2014)35 cited
- → Nasal Glucagon Delivery is More Successful than Injectable Delivery: A Simulated Severe Hypoglycemia Rescue(2020)32 cited
- → Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study(2020)31 cited